Athebio AG’s Post

Athebio AG reposted this

View organization page for Athebio AG, graphic

2,822 followers

🥳 #Athebio has a new Chief Executive Officer! 🥳 We are excited to welcome Thomas Huber, PhD as new CEO to Athebio AG 😊😊😊 (https://lnkd.in/eAdqZ432). With his more than 15 years of experience in drug development in different roles at Novartis, Almirall, biotech incubator Ridgeline Discovery and Granite Bio Thomas is the perfect addition to our team!   His scientific expertise integrates biotherapeutic technologies, immunology, and pharma/biotech principles, facilitating advanced therapeutic approaches. This will significantly contribute to our customer-centric partnering model, anchored on our Athebody® DARPin platform. Moreover, his hands-on experience with therapeutic #antibodies, #multispecifics, therapeutic proteins, #AAV, and #DARPins provides him with a deep understanding of the realm of protein binders. Athebio’s co-founder and #DARPin mastermind Patrik Forrer, who has served as CEO since the company's inception, will transition to the role of Acting Chief Scientific Officer (CSO), in addition to his position as Chairman of the Board.   Thomas, welcome to #Athebio! Here's to a journey of #innovation and #collaboration ahead! #biotechnology  #athebody  #drugdiscovery #proteinengineering

Athebio AG appoints Thomas Huber, PhD as CEO — ATHEBIO

Athebio AG appoints Thomas Huber, PhD as CEO — ATHEBIO

athebio.com

Thomas Ryckmans

Director of Chemistry Ridgeline Therapeutics

5mo

We ll miss you, but well done!

We are very much look forward to working with you Thomas!

Christian Jost

Co-founder | VP Early Partnering

5mo

great to have you aboard, Thomas 😊

Lorenz Kallenbach

Corporate Patent Counsel

5mo

Welcome Thomas! Great to have you on board. I look forward to working with you

Congratulations and all the best Thomas

Patrik Forrer

Entrepreneur at Athebio AG & Philanthropist

5mo

Welcome on board, Thomas! These are exiting times for Athebio; we look forward to building Athebio together with you! 😊

Sakthi Srinivasan, PhD

Customer Project Lead @ Immuneed | Business Development, Immunotoxicity

5mo

Congratulations and well deserved Thomas Huber and to Athebio AG team.

Anders Elm Pedersen

MD, PhD, DMSc. Head of Clinical Development, Senior Medical Director, Nerviano Medical Sciences

5mo

Congratulations - best wished for your new journey. Well deserved in all aspects!!

Congratulations & good start!! 🎊🍾

Seth Ettenberg

President and Chief Executive Officer at BlueRock Therapeutics | Driven by a personal mission to bring impactful therapies to patients and inspire the teams who develop them

5mo

Go Thomas!

See more comments

To view or add a comment, sign in

Explore topics